Education
About Us
Working with TipRanks
Follow Us
Kainos Laboratories, Inc. (JP:4556)
:4556
4556 Stock Chart & Stats
¥1259.00
¥2.00(0.16%)
At close: 4:00 PM EST
¥1259.00
¥2.00(0.16%)
Day’s Range― - ―
52-Week Range¥1,035.00 - ¥1,404.00
Previous CloseN/A
Volume2.10K
Average Volume (3M)3.22K
Market Cap
¥5.08B
Enterprise Value¥2.70B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.7
Beta0.21
Next Earnings
Jan 23, 2026EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield2.63%
Share Statistics
EPS (TTM)29.08
Shares Outstanding4,558,860
10 Day Avg. Volume5,210
30 Day Avg. Volume3,223
Financial Highlights & Ratios
PEG Ratio-62.73
Price to Book (P/B)0.78
Price to Sales (P/S)1.00
P/FCF Ratio8.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4556 FAQ
What was Kainos Laboratories, Inc.’s price range in the past 12 months?
Kainos Laboratories, Inc. lowest stock price was ¥1035.00 and its highest was ¥1404.00 in the past 12 months.
What is Kainos Laboratories, Inc.’s market cap?
Kainos Laboratories, Inc.’s market cap is ¥5.08B.
When is Kainos Laboratories, Inc.’s upcoming earnings report date?
Kainos Laboratories, Inc.’s upcoming earnings report date is Jan 23, 2026 which is in 72 days.
How were Kainos Laboratories, Inc.’s earnings last quarter?
Kainos Laboratories, Inc. released its earnings results on Oct 28, 2025. The company reported ¥29.084 earnings per share for the quarter, beating the consensus estimate of N/A by ¥29.084.
Is Kainos Laboratories, Inc. overvalued?
According to Wall Street analysts Kainos Laboratories, Inc.’s price is currently Overvalued.
Does Kainos Laboratories, Inc. pay dividends?
Kainos Laboratories, Inc. pays a Annually dividend of ¥32 which represents an annual dividend yield of 2.63%. See more information on Kainos Laboratories, Inc. dividends here
What is Kainos Laboratories, Inc.’s EPS estimate?
Kainos Laboratories, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kainos Laboratories, Inc. have?
Kainos Laboratories, Inc. has 4,558,860 shares outstanding.
What happened to Kainos Laboratories, Inc.’s price movement after its last earnings report?
Kainos Laboratories, Inc. reported an EPS of ¥29.084 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.844%.
Which hedge fund is a major shareholder of Kainos Laboratories, Inc.?
Currently, no hedge funds are holding shares in JP:4556
Company Description
Kainos Laboratories, Inc.
Kainos Laboratories, Inc. (4556) is a biotechnology company focused on developing innovative healthcare solutions, primarily in the fields of diagnostics and therapeutics. The company specializes in the research, development, and commercialization of advanced laboratory testing technologies and medical devices that enhance patient care and improve clinical outcomes. Kainos Laboratories operates within the biotechnology sector and is dedicated to delivering high-quality, reliable products that cater to the needs of healthcare providers and patients alike.
Technical Analysis
JMS Co., Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―
Shofu Inc.
―
Shigematsu Works Co., Ltd.
―